Smart watches from the South Korean brand start measuring blood pressure in the United States

From the end of March 2026, North American consumers will have a new cardiovascular monitoring tool directly on their wrist. The South Korean manufacturer began the progressive release of the blood pressure reader for owners of Galaxy Watch smartwatches, starting with the fourth generation of the device. Access to the new feature occurs exclusively through the Samsung Health Monitor digital platform.
For the equipment to be able to record the heartbeat and strength of the blood flow, the owner needs to make a prior adjustment using a traditional sphygmomanometer and keep the brand’s cell phone connected to the mobile internet. Although the functionality had already been released for years in territories such as the European Union and South Korea, its arrival on the American market took time due to the rigorous and long approval processes of the local health regulatory agency, the FDA.

Step by step to configure the biometric reader on your wrist
The initial procedure requires the consumer to download the latest versions of the company’s wellness apps onto the paired smartphone. As soon as the system recognizes the update, the interface displays a prominent notice inviting the individual to enable cardiovascular monitoring.
The synchronization step requires the person to take three consecutive measurements using a conventional arm gauge, while the smart watch captures data simultaneously on the opposite limb. Medical guidelines require that the individual rest for at least five minutes before starting, remaining seated in a comfortable chair, without crossing their legs and with their upper limbs relaxed on a flat surface.
Any consumption of alcoholic beverages, caffeine intake, use of nicotine products or physical activity in the half hour before the test may compromise the accuracy of the numbers. The entire adjustment process only takes a few moments, but the user cannot move their body or speak while the sensors work.
- Use of a clinically validated arm pressure gauge to ensure accuracy of initial data
- Presence of an active operator chip on the Galaxy cell phone to confirm the user’s geographic location
- Carry out three readings in a row, respecting a maximum limit of half an hour between the first and last
- Obligation to repeat the entire synchronization procedure every 28-day cycle to avoid distortions in metrics
Once this initial configuration is successfully completed, the wrist accessory gains autonomy to calculate daily blood pressure levels, dispensing with traditional medical equipment. The tool continues to operate normally on a daily basis, regardless of whether the smartphone loses cell tower signal throughout the day.
Which devices support the new monitoring technology
The software release covers watches from generations 4, 5, 6, 7 and 8, as well as special editions that operate with the Wear OS 4.0 system or higher editions. On the phone side, the requirement is to have a model from the South Korean manufacturer itself running the Android 12 operating system onwards, which completely excludes the possibility of pairing with cell phones from competing companies.
As the code is distributed in batches, it may take a few days for some of the public to see the activation button. The manufacturer advises customers to manually search for update packages in online stores, highlighting that the latest versions of the wearable, such as the Galaxy Watch 8, deliver superior results thanks to improved pulse wave analysis sensors.
Medical restrictions and accuracy of optical sensors
Scientific analyzes conducted since the original launch of the technology in 2020 indicate that the optical reading algorithm has a known behavioral deviation. In specific situations, the system tends to record lower numbers than reality in patients with severe hypertension, while it can inflate the results for people with naturally very low blood pressure.
The highest cardiology entity in South Korea even published a manual of good practices for the use of wearable devices in cardiovascular control. The document reinforces the absolute need to respect body positions during measurement and draws attention to the natural variations in blood flow that occur between the right and left side of the human body.
Patients with complex health conditions, including pregnant women, those with cardiac arrhythmia, chronic kidney disease patients and diabetics without adequate control, should not use the watch as a primary source of information. If the display shows an alarming systolic pressure, falling below 60 mmHg or exceeding the 160 mmHg mark, the individual must seek a hospital or use a clinical meter to confirm the emergency.
Alternatives to making the mandatory monthly adjustment
Drugstore chains sell home sphygmomanometers at prices that fit most families’ budgets. The technology company strongly recommends purchasing models that involve the entire arm, instead of wrist versions, with prices ranging between 20 and 50 dollars in American physical and digital retailers.
For consumers who prefer not to invest in purchasing medical equipment, there is the possibility of visiting a health center or borrowing a meter from a pharmacist to complete the three initial readings. The only unbreakable rule is to guarantee access to that exact same device when the application charges for calibration renewal the following month.
Impact on daily monitoring of chronic patients
Activating this functionality in the United States transforms the routine of those who live with the risk of heart attacks or strokes, facilitating the creation of an invisible health diary. The software compiles long-term graphs, identifies heart behavior patterns and generates reports in digital format that can be sent directly to the responsible doctor’s email.
Healthcare professionals constantly emphasize that smart accessories work as trend radars, never as a substitute for a formal clinical diagnosis. Continuous monitoring of the wrist serves to alert the patient to abnormal pressure peaks early, always requiring a laboratory investigation to confirm any suspicion.
The advancement consolidates the brand’s wellness platform, which already offered the ability to perform electrocardiograms and detect irregular heart rhythms. In a country where almost half of adults suffer from some degree of hypertension, according to public health data, users gain an extra layer of protection and silent surveillance tied to their own arm.






